AF
DXCM icon

Avanza Fonder’s DexCom DXCM Stock Holding History

Avanza Fonder’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Sell
33,413
-7,299
-18% -$486K 0.05% 268
2026
Q1 		$2.56M Sell
40,712
-2,730
-6% -$190K 0.07% 223
2025
Q4 		$2.88M Sell
43,442
-930
-2% -$60.1K 0.07% 220
2025
Q3 		$2.99M Buy
44,372
+36
+0.1% +$2.85K 0.08% 195
2025
Q2 		$3.87M Sell
44,336
-1,019
-2% -$79.9K 0.11% 154
2025
Q1 		$3.09M Sell
45,355
-2,622
-5% -$214K 0.1% 177
2024
Q4 		$3.73M Buy
+47,977
New +$3.55M 0.11% 160

Other funds holding DXCM

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Avanza Fonder's DXCM Position: Q2 2026 in Review

Avanza Fonder reduced its DexCom (DXCM) stake by 18% in Q2 2026, selling an estimated $486K and leaving 33,413 shares worth $2.25M. The position accounts for 0.05% of the portfolio, ranked #268.

Avanza Fonder first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.87M in Q2 2025. 279 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Avanza Fonder held 33,413 shares of DexCom worth $2.25M as of Q2 2026.
  • Avanza Fonder sold 7,299 DexCom shares in Q2 2026, an estimated $486K.
  • DexCom made up 0.05% of Avanza Fonder's portfolio in Q2 2026, its #268 holding.
  • Avanza Fonder first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's DexCom position peaked at $3.87M in Q2 2025.
  • 279 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.